Seeing the glass half full on Canada’s disappointing vaccine rollout

Over the past few weeks, our newsfeeds have been filled with commentary about the relatively slow progression of the vaccine rollout in Canada. This commentary carries a number of criticisms, including condemnation of the negotiation blunders surrounding vaccine shipments, as well as Canada's lack of capacity to manufacture vaccines domestically, ominous predictions of what this means for Canada's economic status, and denunciation of Canada's use of the COVAX program to procure additional vaccines at the expense of lower-income countries.